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Abstract. We have investigated fetal and adult T-cell 
receptor (TCR) A and B V-gene repertoires both by 
fluorescence-activated c ll sorter (FACS) analysis with 
the available TCR V region-specific mAbs and by the 
polymerase chain reaction (PCR) with TCR V gene 
family-specific oligonucleotides. Among the low num- 
ber of CD3 + T cells, most of the TCR V regions tested 
for could be detected by FACS analysis in liver, bone 
marrow, and spleen derived from a 14-week-old fetus 
and two 15-week-old fetuses. Similarly, the PCR ana- 
lysis showed that the majority of the TCRAVand TCRBV 
families were expressed in the peripheral organs of the 
13-week-old fetus, although an apparent absence of 
particular TCR V families was found in liver and bone 
marrow. This was most probably the consequence of the 
low number of CD3 + T cells in these organs. In 17- 
week-old fetal thymi the level of expression of some 
TCRAV and TCRBV gene families, in particular those 
that contain a single member, was lower compared to 
post-partum thymi and adult peripheral blood mono- 
nuclear cells. The combined data of FACS and PCR 
analysis demonstrate hat TCR V genes belonging to the 
majority of TCR V gene families can be used in TCR o: 
and [~ chain rearrangements during early human fetal 
life. Our data also suggest hat the expression levels of 
some of the single member TCR V gene families may be 
influenced by the developmental stage. 
Introduction 
T-lymphocytes specifically recognize processed peptide 
antigens, presented by major histocompatibility com- 
plex molecules, via the T-cell receptor (TCR; reviewed 
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in Strominger 1989). TCRs can be divided into two 
classes: the c~[3 TCR, expressed on the majority of per- 
ipheral T lymphocytes, and the 75 TCR (Brenner et al. 
1986, 1987; Strominger 1989). Both chains of these 
heterodimeric TCRs are composed of variable and 
constant regions. Variable regions are assembled from 
germ-line ncoded variable (V), diversity (D; only pre- 
sent in [3 chains), and joining (J) elements through a 
process called V(D)J recombination (reviewed in Schatz 
et al. 1992). The currently known human TCR V ele- 
ments have been grouped into 29 TCRAV families and 
24 TCRBV families; the majority of these contain only a 
single member (Concannon et al. 1986; Kimura et al. 
1987; Wilson et al. 1988; Ferradini et al. 1991; Plaza et 
al. 1991; Robinson 1991; Roman-Roman et al. 1991). 
Cells committed to the T-cell lineage are detectable 
in human fetal liver as early as the eighth week of ge- 
station, although at this stage of fetal life rearrangement 
of the TCR genes is undetectable (Asma et al. 1983; 
Sfinchez et al. 1993). From 12 weeks of gestation on- 
wards the bone marrow is the primary site of lympho- 
poiesis (Asma et al. 1983, 1984; Gale 1987; Abe 1989). 
The thymus is colonized by (pre) T cells, generated in
the hematopoietic organs at 8 or 9 weeks of gestation, 
and remains the major site for T-cell differentiation and 
selection of the TCR repertoire (Asma et al. 1983, 1984; 
Gale 1987; Haynes et al. 1988; Abe 1989; Sfinchez et al. 
1993). TCRA and TCRB gene rearrangements have been 
detected in the human fetal thymus as early as 15 weeks 
of gestation (Campana et al. 1989) but are likely to be 
initiated at an earlier stage. 
Rearrangement of TCR gene elements is an ordered 
process. For instance, studies of mouse and human 
T-cell development (Born et al. 1985; Samelson et al. 
1985) and analysis of human CD3- T-cell acute lym- 
phoblastic leukemias (Furley et al. 1986; Van Dongen et 
al. 1987) have shown that the TCRB and TCRG loci 
rearrange before the TCRA and TCRD loci. Previously, 
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we and others have demonstrated that the employment 
of the various TCR V gene elements in mouse and 
human TCR 8 chain rearrangements is under develop- 
mental control. Furthermore, the overall usage of 
TCRDV elements is influenced by post-thymic periph- 
eral modification (Elliot et al. 1988; Ito et al. 1989; 
Lafaille et al. 1989; Krangel et al. 1990; Van der Stoep 
et al. 1990). The usage of TCRGV and TCRGJ gene 
elements was found to be tissue-specific during mouse 
fetal life (Lafaille et al. 1989). Some of these observa- 
tions have also been made regarding the usage pattern of 
TCRAJ elements during mouse development (Roth et al. 
1991). 
To gain an insight into the generation of the re- 
pertoire of c~13 chain TCRs and possible developmental 
influences on the usage of TCR V gene families during 
the establishment of the human TCR A and B repertoire, 
we have investigated the usage of TCRAV and TCRBV 
families in TCR rearrangements derived from fetal liver, 
bone marrow, and spleen obtained at 14 (n = 1) and 
15 weeks (n = 2) of gestation, using fluorescence-acti- 
vated cell sorter (FACS) analysis. As the number of 
monoclonal antibodies pecific for human TCR V-re- 
gions is limited and fetal liver and bone marrow contain 
extremely low numbers of T cells, we have also de- 
termined TCRAVand TCRBV gene family expression in 
adult peripheral blood mononuclear cells (PBMC), two 
human post-partum thymi, two human fetal thymi at 
17 weeks of gestation, and in human fetal liver, bone 
marrow, spleen, gut, and cord blood at 13 weeks of 
gestation, using the polymerase chain reaction (PCR). 
Characterization f fetal Tcells by immunological staining. TCR V 
region usage of fetal T cells was analyzed by double staining for 
CD3 with Leu4-PE (Becton Dickinson, Mountain View, CA) or 
OKT3-PE (Ortho Diagnostic Systems, Raritan, NJ) combined with 
V[32- VI33-, V[38-, V[317-, and VI319-specific monoclonal anti- 
bodies (mAbs; Immunotech, Marseille, France) and V~5a-, V[35b-, 
VI35c-, V[36-, V~Sb-, VI312-, Vc~2-, and Vc~12-specific mAbs 
(T cell Sciences, Cambridge, MA), respectively. After washing the 
cells, we detected membrane-bound unconjugated TCR V region- 
specific mAbs with the FITC-labelled IgG fraction of goat antisera 
(Nordic Immunological Laboratories, Tilburg, the Netherlands) 
against the IgG subclass of the particular mAb. 
FACS analysis. Stained ceils were analyzed with a FACS (FAC- 
Star, Becton Dickinson) equipped with an argon ion laser tuned at 
300 mW of 488 nm excitation light. The forward light scatter was 
detected with a photodiode, whereas the orthogonal light scatter 
and red and green fluorescence emission signals were detected by 
photomultiplier tubes. The green and red emission were measured 
with band-pass type interference filters (530130; type no. 19- 
62774-00, and 585/42; type no. 19-62774-03, Becton Dickinson, 
respectively). A 560 nm dichroic mirror (type no. 19-62772-00, 
Becton Dickinson) was used to separate spectrally the FITC and 
the PE emission. All signals were recorded as 256 channel histo- 
grams and stored into list-mode, using a consort-30 computer 
program (Becton Dickinson) on an HP-300 computer system 
(Hewlett Packard). In samples from liver and bone marrow at least 
150000 nucleated cells were analyzed because of the low per- 
centages of CD3 + ceils; for the spleen this figure was at least 
50000 nucleated cells. The data obtained by using the un- 
conjugated TCR V region-specific mAbs followed by mouse IgG 
subclass-specific conjugate were corrected for background staining 
by application of the latter antibody only. 
Optimal setting of the lymphocyte (and blast) gate for cell 
suspensions of the different organs was based on the fluorescence 
pattern obtained after staining of the cells with a cocktail of mAbs 
against CD45 (Becton Dickinson), CD33 (Becton Dickinson), and 
Glycophorin A (Immunotech). 
Materials and methods 
Human organs. Human fetal tissue was acquired by interruption of
pregnancy on nonmedical grounds and used for the experiments 
after informed consent. The gestational ge was determined by 
measurement of the foot length (Moore 1988). As a consequence 
of the suction procedure we were unable to locate the thymi of the 
younger fetuses. The use of this material for research purposes was 
approved by the Ethical Research Committees of the University 
Hospitals of Leiden and Rotterdam under strict conditions. 
To obtain fetal bone marrow, long bones were flushed with 
phosphate buffered saline, containing 5% bovine serum albumin 
(BSA) and 0.25% Na-ethylenediaminetetraacetate (EDTA)and the 
cells were pelleted. Bone marrow of the 11-week-old fetus was not 
investigated, aslymphopoiesis is marginal at this point of gesta- 
tion. For PCR analysis, pelleted bone marrow and the other fetai 
organs were immediately frozen in liquid nitrogen and stored at 
-80 ° C. For FACS analysis, single-cell suspensions were prepared 
from liver, bone marrow, and spleen as previously described (Asma 
et al. 1983, 1984). Mononuclear cells were isolated by Ficoll/ 
Isopaque density gradient centrifugation. Post-partum thymi were 
obtained from pediatric patients undergoing cardiac surgery. Adult 
peripheral blood was obtained by venepuncture from a healthy 
donor; PBMC were isolated by Ficoll/Isopaque density gradient 
centrifugation. 
Method validation. As the number of T cells in fetal iver and bone 
marrow was extremely ow, we assessed whether the percentage of 
T cells expressing the TCRBV3 family as determined by our assay 
was influenced by the number of CD3 + T cells in a given sample. 
We therefore mixed adult PBMC with a CD3- CD10 + pre-B leu- 
kemic cell line in several ratios (100:0, 75:25, 50:50, 25:75). 
The results demonstrated that, irrespective of the ratio, the per- 
centage of TCRBV3 + T cells within the CD3 + population remained 
constant. Therefore, detection of this TCRBV family was not in- 
fluenced by the number of CD3 + T cells present in the sample (data 
not shown). 
RNA extraction, cDNA synthesis, PCR analysis, and Southern 
blotting. RNA was extracted with guanidinium salts, using stan- 
dard laboratory methods (Sambrook et al. 1989) and dissolved into 
40 ~tl of DEPC-treated water. Five ~tg of RNA was used for oligo 
dT-primed cDNA synthesis, using reverse transcriptase (Riboclone 
cDNA synthesis ystem; Promega, Madison, WI). Following 
phenol extraction, the double-stranded cDNA was dissolved in 
100 ~tl TE. The expression of TCRAV and TCRBV gene families 
was analyzed, using PCR amplification as previously described by 
our laboratory (Lambert et al. 1992; Van Eggermond et al. 1993; 
Hawes et aL 1993; Struyk et al. 1993), with minor modifications. 
Briefly, 0.5 ~tl cDNA was amplified, using 20 pmol TCRAV- and 
TCRBV-specific 5' sense primers, 20 pmol 3' antisense TCRAC 
primer or a TCRBC primer specific for both TCRBC1 and TCRBC2 
loci, and 2.5 units Taq DNA polymerase (Boehringer, Mannheim, 
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Fig. 1. FACS profiles of the detection of CD3(Leu4)+V~6+ T cells stained by an FITC-labeled TCRBV6-specific mAb in fetal liver, bone 
marrow (BM), and spleen obtained at 14 and 15 weeks (Fetus 2) of gestation• 
Germany) in the presence of 50 mM KC1, 10 mM Tris-HC1 
(pH 8.4), 4 mM MgClz, 0.5 mM of each dNTP, and 0.06 mg/ml 
BSA in a final volume of 100 gl. PCR cycles consisted of 1 rain 
denaturation at 97 ° C, 1 rain annealing at 54 ° C, and 1 rain ex- 
tension at 74 ° C in a Bio-Med Thermocycler 60. As the amount of 
TCR message within an organ (liver, bone marrow, gut, and cord 
blood as opposed to thymus and spleen) varied greatly, an internal 
control reaction for the total amount of TCR product detected in 
each cDNA preparation was included in the experiments. To this 
end, a PCR reaction was performed, using the 3' antisense TCR C 
primer mentioned above and a sense primer specific for the 5' 
region of the constant gene element. PCR reactions were also 
performed without emplate cDNA as a negative control. In order 
to assess the efficiency of the TCRAV and TCRBV primers, adult 
PBMC were included in all experiments. The analysis of the 
TCRAVand TCRBVrepertoires was repeated at least hree times for 
each organ. The possibility of maternal peripheral blood con- 
tamination was excluded by the lack of detection of IgG-encoding 
transcripts in RNA obtained from the fetal organs (Raaphorst et al. 
1992). 
In order to maximize the chance of detecting TCR rearrange- 
ments that might be present at trace levels, the PCR reactions were 
performed for up to 40 cycles. The sequences of the primers have 
been described (Choi et aL 1989; Oksenberg et al. 1990; Lambert et al. 1992; Hawes et al. 1993; Stmyk et al. 1993). 
Ten gl of the PCR reactions and serial dilutions (undiluted 
5 times, and 25 times diluted) of the internal control amplifications 
were fractionated on a 1% agarose gel in 0.5 x tris-borate, blotted 
onto nylon membranes (Biotrace HP; Gelman Sciences, Ann 
Arbor, MI), and screened with 32P-labeled probes specific for the 
TCRAC or TCRBC region, according to protocols upplied by the 
manufacturer of the membranes. Autoradiography was performed 
using Kodak XAR films (Rochester, NY). 
Results 
FACS analysis of TCR V gene expression in fetal liver, 
bone marrow, and spleen. In Table 1 the results of  the 
FACS analysis of  TCR V gene usage by human fetal 
T cells, obtained at 14 (n = 1) and 15 weeks (n = 2; 
fetus 1 and 2) of  gestation, are shown. A representative 
example of  the FACS profi les obtained for detection of  
TCR V gene expression within various fetal tissues is 
presented in Figure 1. CD3 + T cells expressing the 
various TCRAV and TCRBV gene elements were de- 
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tectable in all fetal tissues analyzed but were, in contrast 
to spleen, present at extremely low numbers in liver and 
bone marrow. For instance, in the liver and bone mar- 
row of 14- and 15-week-old fetuses, approximately 
0.35% to 2.5% of the gated nucleated cells were CD3 ÷ 
(data not shown). Most TCRAV and TCRBV gene fa- 
milies tested for were expressed in these fetal organs, 
albeit at different levels. As shown in Table 1, the de- 
gree of expression of these TCRAV and TCRBV gene 
families appeared to be subject o individual differences. 
This is exemplif ied by the expression level of the 
Table 1. FACS analysis of membrane-expressed TCR Velements. 
V chain 14-wk fetus 15-wk fetus 15-wk fetus 
(1) (2) 
L V32 
V33 
T ~5a 
V 35b 
V 35c 
V 36 
V38 
V 38b 
V312 
V317 
V319 
Vc~2 
VcO2 
V32 
V33 
V 35a 
V 35b 
V 35c 5.0 
V 36 4.0 
V 38 4.8 
V 38b 5.5 
V312 6.2 
V317 5.2 
V319 7.4 
Vc~2 2.9 
VcO2 5.0 
S V~2 10.2 
v~3 1.1 
V[35a 2.6 
V135b 0.9 
v[35c 3.5 
v~6 1.3 
V[38 3.4 
VI38b 2.3 
V[512 4.6 
V1317 0.3 
v~a9 2.8 
Vc~2 1.8 
VcO2 1.8 
B__N 
5.3 7.5 
4.5 4.3 
4.3 2.8 
4.6 2.7 
6.7 5.3 
5.0 1.8 
7.0 
5.5 
7.6 2.5 
0.7 
6.5 4.8 
2.5 6.1 
4.1 
10.9 8.0 
0.0 4.0 
2.0 
0.7 4.0 
1.8 8.6 
4.2 4.3 
7.9 
4.5 
5.4 
0.0 
7.2 
0.8 
3.3 
4.2 5.7 
9.2 3.6 
3.1 
2.6 0.8 
6.7 
2.5 
7.5 
3.2 
5.2 
0.0 
3.4 
2.8 
4.0 
1.9 
1.8 
2.0 
0.8 
2.7 
2.1 
2.7 
2.0 
2.7 
0.4 
1.5 
1.8 
1.4 
7.7 
7.4 
2.0 
5.7 
FACS analysis of membrane-expressed TCR V elements by CD3 + 
T cells isolated from liver (L), bone marrow (BM), and spleen (S) 
of a 14-week-old human fetus and two 15-week-old fetuses (Fetus 1 
and Fetus 2). Values are expressed as the percentage of CD3 + 
T cells expressing the indicated V chain; - --- not done. 
Fig. 2. TCRBV gene family repertoire analyzed by PCR in two 
human fetal thymi (17 weeks of gestation; FT1 and FT2), two post- 
partum thymi (AT1 and AT2), and adult PBMC (all 26 cycles). C-C 
is the serially diluted control amplification ofthe constant locus of 
the TCR. Note: TCRBV5 rearrangements were detected in two 
separate PCR reactions, using two different primers (TCRBV5a nd 
TCRBV5b). 
TCRVB2 element, which differed when the liver and 
spleen obtained from two age-matched fetuses (fetus 1 
and 2) were compared. Variable patterns of TCR V-gene 
usage could be discerned for other Velements analyzed 
as well. 
PCR analysis of TCR V gene expression in thymi. To 
expand our studies with mAbs, we subsequently de- 
termined the expression of TCRBVand TCRAVelements 
by PCR. In Figures 2 and 3 the Southern analyses of the 
expression of TCRBV and TCRAV families in two 
human fetal thymi at 17 weeks of gestation (FT1 and 
FT2) and two post-partum thymi (AT1 and AT2) in 
comparison to adult PBMC are shown. The majority of 
the TCRBV and the TCRAV families were detectable in 
the post-partum thymi and adult PBMC. The expression 
level of TCRBV and TCRAV families in the fetal thymi 
was subject o more variation: although the frequency of 
usage of the majority of the multi-member families 
(TCRBV1-TCRBV8 and TCRBVIO-TCRBV13) was 
comparable in FT1, FT2, AT1, and AT2, the majority 
of the single-member families (for instance the 
TCRBV15-TCRBV18 and the recently identified 
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TCR V-alpha 
FT1 
1 6 11 16 21 26 c-c 
TCR V-beta 
LIVER 
1 6 11 16 21 c-c 
FT2 
1 
AT1 
1 6 11 16 
AT2 
1 6 11 16 
6 11 16 21 26 c-¢ 
21 26 c-¢ 
21 26 c-c 
PBMC 
1 6 11 16 21 26 c-¢ 
BONE MARROW 
1 6 11 16 
GUT 
1 6 
21 
11 16 21 
SPLEEN 
1 6 11 16 21 
C-C 
C--C 
C-C 
Fig. 3. TCRAVrepertoire analyzed by PCR following 30 cycles in 
two human fetal thymi (17 weeks of gestation; FT1 and F]?2), two 
post-partum thymi (AT1 and AT2), and adult PBMC. 
TCRAV24-TCRAV29 gene families) appeared to be ex- 
pressed at a lower level in both fetal thymi. 
PCR analysis of TCR V gene expression in fetal liver, 
bone marrow, spleen, gut, and cord blood. Determina- 
tion of the TCRBV repertoire in the 13-week-old fetus 
showed that almost all of the TCRBV families were 
detectable in cord blood, gut, and spleen, whereas 
TCRBV gene usage appeared to be restricted in liver and 
bone marrow (Fig. 4). Similarly, most of the TCRAV 
families tested for were readily detectable in the per- 
ipheral organs of the 13-week-old fetus with the ex- 
ception of the TCRAV24-TCRAV29 single-member gene 
families (Fig. 5). As found in the analysis of TCRBV 
gene families, the level of expression of the various 
TCRAV gene families differed markedly in 13-week-old 
fetal liver and bone marrow compared to the expression 
of these TCRAV gene families in the periphery. In the 
11-week-old fetus, the TCRBV gene family usage pro- 
files exhibited a restricted pattern in both hematopoietic 
and peripheral organs which was most likely related to 
the low percentage of CD3 + T cells in fetal organs at this 
gestational age. In addition, TCRAV rearrangements 
were barely detectable in the investigated organs of this 
fetus (data not shown). 
CORD BLOOD 
1 6 11 16 21 c-c 
! 
Fig. 4. TCRBV repertoire analyzed by PCR in human fetal liver 
(35 cycles), bone marrow (35 cycles), gut (30 cycles), spleen 
(30 cycles), and cord blood (35 cycles) obtained from a human 
fetus at 13 weeks of gestation. Note: TCRBV5 rearrangements were 
detected in two separate PCR reactions, using two different 
primers (TCRBV5a and TCRBV5b). 
Discussion 
PCR analysis of the usage patterns of TCRAV and 
TCRBV families by T cells in adult PBMC and post- 
partum thymi indicated that all families identified to 
date were detectable in these tissues. In the oldest fetal 
samples analyzed, the 17-week-old thymi, the majority 
of the TCR V gene families were detectable as well, 
although some families appeared to be underrepresented 
in comparison to post-partum thymi and adult peripheral 
blood. This was most clearly illustrated by considering 
the single-member TCRAV and TCRBV gene families. 
The employment of the various TCRAV and TCRBV 
families as detected by PCR in the 13-week-old per- 
ipheral fetal tissues (gut, spleen, and cord blood) was 
extensive, and more diverse than the repertoire of the 
T ceils in the corresponding primary hematopoietic or- 
gans (liver and bone marrow). 
In analogy with mouse fetal T-cell development 
(Roth et al. 1991) and human fetal B-cell development 
(Schroeder and Wang 1990; Raaphorst et al. 1992), the 
apparent restrictions in human TCRAV and TCRBV fa- 
mily expression could reflect actual preferential usage 
of TCR V gene elements in T-cell precursors derived 
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TCR V-alpha 
LIVER 
1 6 11 16 21 26 C-C 
BONE MARROW 
1 6 11 16 21 26 c-c 
GUT 
1 6 11 16 21 26 c-c 
SPLEEN 
1 6 ~ 16 21 26 C-¢ 
CORD BLO00 
1 6 11 16 21 26 c-¢ 
Fig. 5. TCRAV repertoire analyzed by PCR in human fetal liver 
(37 cycles), bone marrow (38 cycles), gut (35 cycles), spleen 
(35 cycles), and cord blood (35 cycles) obtained from the same 
fetus at 13 weeks of gestation. 
1992). It is of note that TCR V gene family-specific PCR 
reactions were designed to detect all known members of 
a given family. Consequently, this may also explain why 
the FACS and PCR analyses were not completely 
overlapping, because the mAbs used are specific for a 
single member only. 
As the peripheral fetal TCR V gene repertoire was 
extensive both in PCR and FACS analysis, our data 
show that in early human fetal TCR rearrangements V 
elements belonging to the majority of TCR V gene fa- 
milies are used by fetal T cells. Recently reported ata 
obtained by other groups support his conclusion: stu- 
dies of TCRBV expression in human fetal thymus and 
spleen at 15-22 weeks of gestation also demonstrated 
that all of the 20 tested TCRBV gene families can be 
used in TCR rearrangements at this stage of fetal de- 
velopment (Doherty et al. 1991; Bonati et al. 1992). In 
addition, transplantation f 18- to 20-week-old human 
fetal thymus and liver in SCID-hu mice demonstrated 
that all investigated TCRBVelements were expressed by 
the repopulating T cells (VandeKerckhove etal. 1992). 
Furthermore, the relative expression levels of TCRBV 
elements expressed by T cells in the SCID-hu fetal 
thymus differed in comparison to the TCRBV usage 
patterns of T cells in human post-partum thymi (Doherty 
et al. 1991; VandeKerckhove et al. 1992), which is 
compatible with our results. 
Taken together, our data indicate that there are no 
apparent major limitations in the usage of TCRAV and 
TCRBV gene families in the fetal and adult tissues 
analyzed. 
from liver and bone marrow at early fetal ages. How- 
ever, considering the more diverse TCR repertoire in the 
periphery of these fetuses, the low number of immature 
and mature CD3 + T cells, especially in the hemato- 
poietic tissues, probably lies at the heart of the apparent 
restricted phenotype of TCR V family usage. This was 
reflected by the number of cycles of PCR required to 
obtain a comparable l vel of detection in the various 
tissues (Figs. 2-5). Also, FACS analysis of the ex- 
pression of TCRAVand TCRBV gene products of CD3 + 
T-cells in 14- and 15-week-old fetal liver, bone marrow, 
and spleen (Fig. 1; Table 1) indicated that the majority 
of the TCR V regions tested for were detectable, al- 
though sometimes at an extremely low level. The per- 
centage of staining of CD3 + T cells in fetal tissue for 
each individual mAb was in a range similar to the 
staining patterns in PBMC, as previously reported by 
our group (Lambert et al. 1992; Hawes et al. 1993). The 
mAb staining profiles suggested that the patterns of 
expression of TCR V families were subject o individual- 
specific variation, which has recently also been de- 
scribed in several other studies of TCR V gene expres- 
sion in unrelated individuals (Akolkar et al. 1992; Ro- 
binson 1992; Rosenberg et al. 1992; Hawes et al. 1993) 
and T-cell subsets (Davey et al. 1991; Grunewald et al. 
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